The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders
about
The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The use of surrogate endpoints ...... ease: opinions of stakeholders
@ast
The use of surrogate endpoints ...... ease: opinions of stakeholders
@en
The use of surrogate endpoints ...... ease: opinions of stakeholders
@nl
type
label
The use of surrogate endpoints ...... ease: opinions of stakeholders
@ast
The use of surrogate endpoints ...... ease: opinions of stakeholders
@en
The use of surrogate endpoints ...... ease: opinions of stakeholders
@nl
prefLabel
The use of surrogate endpoints ...... ease: opinions of stakeholders
@ast
The use of surrogate endpoints ...... ease: opinions of stakeholders
@en
The use of surrogate endpoints ...... ease: opinions of stakeholders
@nl
P2093
P2860
P1433
P1476
The use of surrogate endpoints ...... ease: opinions of stakeholders
@en
P2093
Bauke Schievink
Dick De Zeeuw
Hiddo Lambers Heerspink
Hubert Leufkens
Jarno Hoekman
P2860
P304
P356
10.1371/JOURNAL.PONE.0108722
P407
P577
2014-01-01T00:00:00Z